Menu Close

Rezny Wealth Management Inc. Boosts Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

view original post

Rezny Wealth Management Inc. raised its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBIGet Rating) by 20.3% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 33,985 shares of the exchange traded fund’s stock after acquiring an additional 5,739 shares during the quarter. SPDR S&P Biotech ETF makes up 1.0% of Rezny Wealth Management Inc.’s investment portfolio, making the stock its 13th largest position. Rezny Wealth Management Inc.’s holdings in SPDR S&P Biotech ETF were worth $3,054,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Axiom Investment Management LLC purchased a new position in SPDR S&P Biotech ETF during the 4th quarter valued at about $25,000. Integrity Financial Corp WA acquired a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter worth about $29,000. Concorde Financial Corp acquired a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter worth about $33,000. Aptus Capital Advisors LLC acquired a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter worth about $41,000. Finally, Prestige Wealth Management Group LLC boosted its stake in shares of SPDR S&P Biotech ETF by 49.0% during the 4th quarter. Prestige Wealth Management Group LLC now owns 377 shares of the exchange traded fund’s stock worth $42,000 after purchasing an additional 124 shares during the last quarter.

SPDR S&P Biotech ETF Stock Down 1.7 %

SPDR S&P Biotech ETF stock opened at $81.13 on Friday. SPDR S&P Biotech ETF has a 12-month low of $61.78 and a 12-month high of $136.61. The firm’s 50-day moving average is $74.91 and its two-hundred day moving average is $82.33.

SPDR S&P Biotech ETF Company Profile

(Get Rating)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

See Also

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBIGet Rating).

Receive News & Ratings for SPDR S&P Biotech ETF Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com’s FREE daily email newsletter.